| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |